Clinical research organisation (CRO) Icon has begun the integration of Medidata Clinical Data Studio into its clinical ...

The US is set to withdraw from the WHO following Trump's disagreements regarding the agency's handling of the Covid-19 ...

Onctura has dosed the first subject in the Phase II OCULE-01 trial of oral roginolisib in individuals with metastatic uveal ...

IGC Pharma has added HHS in Canada as a new clinical site for its Phase II CALMA trial of IGC-AD1 to treat agitation in ...

The two simultaneous Incyte trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face government funding cuts.

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

Regenxbio has reported positive interim data from the Phase I/II portion of its Affinity Duchenne study, which is examining ...

NACE has collaborated with 17 Australian general practices and allergy clinics to launch the ARISE trial for young people with hay fever.

Innovent and HUTCHMED received conditional approval for the combo in endometrial cancer from China’s NMPA last year.

Immunovant will use results from its Phase III myasthenia gravis study to support pipeline candidate IMVT-1402 over the trial ...

Ocugen has received approval from the DSMB to begin dosing the second cohort of patients in a trial of OCU200 for diabetic ...